Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9477128rdf:typepubmed:Citationlld:pubmed
pubmed-article:9477128lifeskim:mentionsumls-concept:C0023418lld:lifeskim
pubmed-article:9477128lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:9477128lifeskim:mentionsumls-concept:C0006840lld:lifeskim
pubmed-article:9477128lifeskim:mentionsumls-concept:C0035648lld:lifeskim
pubmed-article:9477128lifeskim:mentionsumls-concept:C0010711lld:lifeskim
pubmed-article:9477128lifeskim:mentionsumls-concept:C1527148lld:lifeskim
pubmed-article:9477128lifeskim:mentionsumls-concept:C0444956lld:lifeskim
pubmed-article:9477128lifeskim:mentionsumls-concept:C0205164lld:lifeskim
pubmed-article:9477128pubmed:issue5-6lld:pubmed
pubmed-article:9477128pubmed:dateCreated1998-3-30lld:pubmed
pubmed-article:9477128pubmed:abstractTextA retrospective study of hepatosplenic candidiasis in patients with acute leukemia from a single centre was performed. The significance of age, sex, type of leukemia, dose of cytosine arabinoside (Ara-C), duration of neutropenia, steroid use and period of therapeutic antibiotics in the development of hepatosplenic candidiasis was analyzed, using logistic regression analysis. Nine of 51 patients had hepatosplenic candidiasis. Ara-C use was highly associated with the development of hepatosplenic candidiasis (p = 0.001); with a high association with a higher dose (p < 0.0001). On the basis of these results consideration should be given to further trial of antifungal prophylaxis for patients receiving high dose Ara-C.lld:pubmed
pubmed-article:9477128pubmed:languageenglld:pubmed
pubmed-article:9477128pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9477128pubmed:citationSubsetIMlld:pubmed
pubmed-article:9477128pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9477128pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9477128pubmed:statusMEDLINElld:pubmed
pubmed-article:9477128pubmed:monthNovlld:pubmed
pubmed-article:9477128pubmed:issn1042-8194lld:pubmed
pubmed-article:9477128pubmed:authorpubmed-author:SvábZZlld:pubmed
pubmed-article:9477128pubmed:authorpubmed-author:CurtisDDlld:pubmed
pubmed-article:9477128pubmed:authorpubmed-author:SpelmanDDlld:pubmed
pubmed-article:9477128pubmed:authorpubmed-author:FairleyCClld:pubmed
pubmed-article:9477128pubmed:authorpubmed-author:UgoniAAlld:pubmed
pubmed-article:9477128pubmed:authorpubmed-author:WoolleyIIlld:pubmed
pubmed-article:9477128pubmed:authorpubmed-author:VujovicOOlld:pubmed
pubmed-article:9477128pubmed:issnTypePrintlld:pubmed
pubmed-article:9477128pubmed:volume27lld:pubmed
pubmed-article:9477128pubmed:ownerNLMlld:pubmed
pubmed-article:9477128pubmed:authorsCompleteYlld:pubmed
pubmed-article:9477128pubmed:pagination469-74lld:pubmed
pubmed-article:9477128pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:9477128pubmed:meshHeadingpubmed-meshheading:9477128-...lld:pubmed
pubmed-article:9477128pubmed:meshHeadingpubmed-meshheading:9477128-...lld:pubmed
pubmed-article:9477128pubmed:meshHeadingpubmed-meshheading:9477128-...lld:pubmed
pubmed-article:9477128pubmed:meshHeadingpubmed-meshheading:9477128-...lld:pubmed
pubmed-article:9477128pubmed:meshHeadingpubmed-meshheading:9477128-...lld:pubmed
pubmed-article:9477128pubmed:meshHeadingpubmed-meshheading:9477128-...lld:pubmed
pubmed-article:9477128pubmed:meshHeadingpubmed-meshheading:9477128-...lld:pubmed
pubmed-article:9477128pubmed:meshHeadingpubmed-meshheading:9477128-...lld:pubmed
pubmed-article:9477128pubmed:meshHeadingpubmed-meshheading:9477128-...lld:pubmed
pubmed-article:9477128pubmed:meshHeadingpubmed-meshheading:9477128-...lld:pubmed
pubmed-article:9477128pubmed:meshHeadingpubmed-meshheading:9477128-...lld:pubmed
pubmed-article:9477128pubmed:meshHeadingpubmed-meshheading:9477128-...lld:pubmed
pubmed-article:9477128pubmed:meshHeadingpubmed-meshheading:9477128-...lld:pubmed
pubmed-article:9477128pubmed:meshHeadingpubmed-meshheading:9477128-...lld:pubmed
pubmed-article:9477128pubmed:meshHeadingpubmed-meshheading:9477128-...lld:pubmed
pubmed-article:9477128pubmed:year1997lld:pubmed
pubmed-article:9477128pubmed:articleTitleHigh dose cytosine arabinoside is a major risk factor for the development of hepatosplenic candidiasis in patients with leukemia.lld:pubmed
pubmed-article:9477128pubmed:affiliationDepartment of Medicine, Case Western Reserve University, Cleveland, Ohio, USA.lld:pubmed
pubmed-article:9477128pubmed:publicationTypeJournal Articlelld:pubmed